Analyst firms · Morgan Stanley · SAGE

Morgan Stanley SAGE price target and rating history

Sage Therapeutics Inc. (SAGE) · Health Care

Morgan Stanley rates Sage Therapeutics Inc. (SAGE) Equal-Weight with a $57 price target, as of its latest action on Mar 10, 2022. It has published 3 rating actions on SAGE since October 2021, including 0 upgrades and 0 downgrades.

Current rating
Equal-Weight
Price target
$57
Median target, all firms
Too few
Actions on SAGE
3

Morgan Stanley price target on SAGE

$78$68$5720222023202420252026
Morgan Stanley price target on SAGE, each point a stated target, October 2021 to March 2022.

Every Morgan Stanley rating on SAGE

Questions about Morgan Stanley and SAGE

What is Morgan Stanley's price target for SAGE?
Morgan Stanley's latest stated price target for Sage Therapeutics Inc. (SAGE) is $57, from its action on Mar 10, 2022.
What is Morgan Stanley's rating on SAGE?
Morgan Stanley rates SAGE Equal-Weight, a neutral rating, as of Mar 10, 2022.
When did Morgan Stanley last change its view on SAGE?
On Mar 10, 2022, Morgan Stanley cuts its price target to $57 from $61, keeps Equal-Weight.

More SAGE rating histories

All Morgan Stanley ratingsSAGE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.